FULL DISCLOSURE: Altamira Gold is a sponsor of theDeepDive.ca.
Altamira Gold (TSXV: ALTA) has strengthened its technical advisor team, announcing this morning the appointment of Dr. Richard Sillitoe to support exploration work being conducted at Altamira’s flagship Cajueiro porphyry gold district in Brazil.
“We are very pleased to have Dick join us at a key stage for the Company. We have multiple gold prospects in a demonstrated porphyry district at Cajueiro. His knowledge of mineralized porphyry and epithermal systems is unmatched, and his perspective will help us refine our targeting and advance the porphyry potential we are seeing across our Cajueiro District. With two rigs currently drilling on site, we will continue follow-up drilling of the new discoveries and move ahead with expansion drilling at the Maria Bonita and Central gold deposits,” commented Altamira CEO Mike Bennett on the appointment.
READ: Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres
Sillitoe is referred to as ‘one of the world’s leading authorities’ on both porphyry and epithermal systems. Sillitoe is said to have more than five decades of experience as an independent consultant in the field, having worked with mining firms, international agencies, and governments across over 100 countries.
Sillitoe’s experience is backed by more than 130 technical papers and several books that have documented major discoveries through the circum-Pacific region, with Sillitoe also said to have been involved in the discovery and development of major copper and precious metals projects globally.
Dr. Sillitoe holds a PhD from the University of London, after having begun his career with the Geological Survey of Chile.
Altamira Gold last traded at $0.26 on the TSX Venture.
FULL DISCLOSURE: Altamira Gold Corp is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Altamira Gold. The author has been compensated to cover Altamira Gold on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.
